drugset / Trial / NCT04161053
Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Efficacy and Safety of Nitazoxanide in preventing recurrence of Hepatic Encephalopathy.
Timeline
- Start
- 2018-11-01
- Primary completion
- 2028-11
- Completion
- 2028-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nitazoxanide | Other / unclassified | 500 mg | — |
| Comparator | Rifaximin | Other / unclassified | 550 mg | — |